Estimates Revisions Gilead Sciences, Inc. Buenos Aires S.E.
Stocks
GILD
ARBCOM4601C4
Pharmaceuticals
|
End-of-day quote
Buenos Aires S.E.
2026-09-08
|
5-day change | 1st Jan Change | ||
| 58,200.00 ARS | -3.48% |
|
-2.18% | +24.20% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Gilead Sciences, Inc.(GILD)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Gilead Sciences, Inc.(GILD)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Gilead Sciences, Inc.(GILD)
EBIT
Dividend / Share (DPS)
Data source:
Gilead Sciences, Inc.(GILD)
Cash or Net Debt
- Stock Market
- Stocks
- GILD Stock
- GILD Stock
- Consensus Gilead Sciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
